Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Changes in Serum IL-2 Levels Following a Single Oral Dose of Gluten

NCT05209568 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT05209568
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05209568 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Changes in Serum IL-2 Levels Following a Single Oral Dose of Gluten
Lead sponsor
Boston Children's Hospital
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
January 15, 2023
Completion date
September 30, 2029
Enrollment
400 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

celiac disease, celiac disease in children, digestive system disease, gastrointestinal diseases, gluten sensitivity, intestinal disease, malabsorption syndromes